शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEAdline Chem Lab Ltd· Pharmaceuticals & BiotechnologyCriticalNegative
Announced Wed, 12 Nov, 2025 · 18:53 IST

Resignation of Director

CEO resignedKey managerial personnel resignedManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.9%Reaction day
₹12.78
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-4.8% vs market
Pharmaceuticals peers, median of 157sector-0.0%-4.9% vs sector

On the reaction day the stock moved 4.8 pts less than Nifty Microcap 250 and 4.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.9-0.1-4.8-0.0-4.9
Next day
-8.5-0.2-8.3-0.4-8.0
2d
-12.8+0.4-13.2-0.3-12.4
3d
-17.1-0.4-16.7-1.0-16.0
4d
-21.0-0.6-20.4-1.3-19.7
5d
-24.4-0.9-23.5-1.5-22.9
1w
—-3.0—-3.3—
15d
—-3.9—-3.4—
1m
-37.6-4.8-32.7-4.0-33.5
2m
-16.7-7.8-8.9-6.6-10.0
3m
—-7.2—-8.7—
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Adline Chem Lab Ltd informed the stock exchange that two directors resigned from the board effective November 12, 2025, citing personal and other pre-occupations. Mr. Sarang Bharatbhai Pathak stepped down as Executive Director-Chairperson (Managing Director), and Mr. Hemant Amrish Parikh resigned as Non-Executive Promoter Director. Both confirmed there were no other material reasons behind their exit. The Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee have been reconstituted effective November 13, 2025, now comprising independent directors and one executive promoter director, Mr. Vrushankbalkrushna Patel.

Likely market impact

The simultaneous exit of the Managing Director and a Promoter Director on the same day is a significant leadership change for this small company and may raise governance concerns among shareholders. With the reconstitution placing independent directors in charge of key committees, the board appears to have acted quickly to fill gaps, but investors should watch for further clarity on succession and any impact on business operations.